Diltiazem vs Ipilimumab

Diltiazem vs Ipilimumab: Overview

This comparison examines the pharmacological differences between Diltiazem and Ipilimumab.

Mechanism of Action

Diltiazem: Benzothiazepine calcium channel blocker.

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Pharmacokinetics

Half-life: Diltiazem — 3-4.5 hours; Ipilimumab — 14.7 days.

Chemical Properties

Molecular Formula: Diltiazem — C22H26N2O4S.

Molecular Weight: Diltiazem — 414.5190 g/mol.

Type: Diltiazem — Small molecule; Ipilimumab — Antibody.